Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ (original) (raw)

References

  1. Parker, S.L. et al. Cancer statistics. CA Cancer J. Clin. 46, 5–27 (1996).
    Article CAS Google Scholar
  2. Symonds, H. et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703–711 (1994)
    Article CAS Google Scholar
  3. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J. Clin. Oncol. 10, 896–903 (1992).
  4. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).
    Article CAS Google Scholar
  5. Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).
    Article CAS Google Scholar
  6. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49–53 (1991).
    Article CAS Google Scholar
  7. Levine, A., Momand, J. & Finlay, C.A. p53 tumor suppressor gene. Nature 351, 453–456 (1991).
    Article CAS Google Scholar
  8. Boyle, P., Zaridze, D.G. & Smans, M. Descriptive epidemiology of colorectal cancer. Int. J. Cancer 36, 9–18 (1985).
    Article CAS Google Scholar
  9. Byers, T. & Perry, G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu. Rev. Nutr. 12, 139–159 (1992).
    Article CAS Google Scholar
  10. Stone, W.L. & Papas, A.M. Tocopherols and the etiology of colon cancer. J. Norl. Cancer Inst. 89, 1006–1014 (1997).
    Article CAS Google Scholar
  11. Greenwald, P., Kelloff, G.J., Burch-Whitman, C. & Kramer, B.S. Chemoprevention. CA Cancer. J. Clin. 45, 31–49 (1995).
    Article CAS Google Scholar
  12. Turley, J.M. et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor β. Cell. Growth Differ. 6, 655–663 (1995).
    CAS PubMed Google Scholar
  13. Tsai, J.C. et al. Induction of apoptosis by pyrrolidinedithiocarbamate and _N_-acetyl-cysteine in vascular smooth muscle cells. J. Biol. Chem. 271, 3667–3670 (1996).
    Article CAS Google Scholar
  14. Church, S.L. et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Notl. Acad. Sci. USA 90, 3313–3317 (1993).
    Google Scholar
  15. Rautalahti, M. & Antioxidants and carcinogenesis. Ann. Med. 25, 435–441 (1993).
    Google Scholar
  16. Irani, K. et al. Mitogenic signaling mediated by oxidants in ras-transformed fibrob-lasts. Science 275, 1649–1652 (1997).
    Article CAS Google Scholar
  17. Herrmann, R. Biochemical modulation of 5-fluorouracil. Cancer Treat. Rev. 17, 51–55 (1990).
    Article CAS Google Scholar
  18. Cummings, J. Anderson, L., Willmott, N. & Smyth, J.F. The molecular pharmacology of doxorubicin in vivo. Eur. J. Cancer 27, 532–535 (1991).
    Article CAS Google Scholar
  19. Peters, G.J. et al. Thymidylate synthase and drug resistance. Eur. J. Concer 31, 1299–1305 (1995).
    Article Google Scholar
  20. Bendich, A. & Machlin, L.J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48, 612–619 (1988).
    Article CAS Google Scholar
  21. Sunderman, F.W. Therapeutic properties of sodium diethyldithiocarbamate: Its role as an inhibitor in the progression of AIDS. Ann. Clin. Lab. Sci. 21, 70–81 (1991).
    PubMed Google Scholar
  22. Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G, cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).
    Article CAS Google Scholar
  23. Gorospe, M., Wang, X., Guyton, K.Z. & Holbrook, N.J. Protective role of p21 (Waf 1 /Cip1) against prostaglandin A2-mediated apoptosis in human colorectal cancer cells. Mol. Cell. Biol. 16, 6654–6660 (1996).
    Article CAS Google Scholar
  24. Polyak, K., Waldman, T., He, T.C., Kinzler, K.W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1996).
    Article CAS Google Scholar
  25. Wang, J. & Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359–361 (1996).
    Article CAS Google Scholar
  26. Wu, G.S. & EI-Deiry, W.S. Apoptotic death of tumor cells correlates with chemosensitivity of p53 or Bcl-2. Clin. Cancer Res. 2, 623–633 (1996).
    CAS PubMed Google Scholar
  27. Prahbu, N.S. et al. Suppression of cancer cell growth by adenovirus expressing p21WAF1/CIP1deficient in PCNA interaction. Clin. Cancer Res. 2, 1221–1230 (1996).
    Google Scholar
  28. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. & Howley, P.M. The E6 onco-protein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136 (1990).
    Article CAS Google Scholar
  29. Kubbutat, M.H.G. & Vousden, K.H. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies. Semin. Viral. 7, 295–304 (1996).
    Article CAS Google Scholar
  30. Waldman, T., Kinzler, K.W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).
    CAS Google Scholar
  31. EI-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
    Article Google Scholar
  32. Landschulz, W.H., Johnson, P.F., Adahi, E.Y., Graves, B.J. & McKnight, S.L. Isolation of a recombinant copy of the gene encoding C/EBP gene. Genes Dev, 2, 786–800 (1988).
    Article CAS Google Scholar
  33. Akira, S. et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBOJ. 9, 1897–1906 (1990).
    Article CAS Google Scholar
  34. Poli, V., Mancini, F.P. & Cortese, R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643–653 (1990).
    Article CAS Google Scholar
  35. Cao, Z., Umek, R.M. & McKnight, S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5, 1538–1552 (1991).
    Article CAS Google Scholar
  36. Williams, S.C., Cantwell, C.A. & Johnson, P.F. A family of C/EBP-related proteins capable of forming covalently linked leucine zippers dimers in vitro. Genes Dev. 5, 1553–1567 (1991).
    Article CAS Google Scholar
  37. Akira, S. & Kishimot, T. IL-6 and NF-IL6 in acute-phase response to viral infection. Immunol. Rev. 127, 25–50 (1992).
    Article CAS Google Scholar
  38. Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R. & Darlington, G.J. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1 /CIP-1 /SDI-1) protein. Genes Dev. 10, 804–815 (1996).
    Article CAS Google Scholar
  39. Isshiki, H. et al. Constitutive and interleukin-1 (IL-l)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol. Cell. Biol. 10, 2757–2764 (1990).
    Article CAS Google Scholar
  40. Vasseur-Cognet, M. & Lane, M.D. Trans-acting factors involved in adipogenic differentiation. Curr. Opin. Gen. Dev. 3, 238–245 (1993).
    Article CAS Google Scholar
  41. Beg, A.A. & Baltimore, D. An essential role of NF-κB in preventing TNF—induced cell death. Science 274, 782–784 (1996).
    Article CAS Google Scholar
  42. Wang, C.Y., Mayo, M.W. & Baldwin, A.S. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274, 784–787 (1996).
    Article CAS Google Scholar
  43. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787–789 (1996).
    Article CAS Google Scholar
  44. Grimm, S., Bauer-Manuel, K.A., Baeuerle, P.A. & Schulze, K.O. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell. Biol. 134, 13–23 (1996).
    Article CAS Google Scholar
  45. Schreck, R., Grassmann, R., Fleckenstein, B. & Baeuerle, P.A. Antioxidants selectively suppress activation of NF-kappaB by human T-cell leukemia virus type I Tax protein. J. Virol. 66, 6288–6298 (1992).
    CAS PubMed PubMed Central Google Scholar
  46. Traenckner, E.B. et al. Phosphorylation of human I kappaB-alpha on serines 32 and 36 controls I kappaB-alpha proteolysis and NF-kappaB activation in response to diverse stimuli. EMBO J. 14, 2876–2883 (1995).
    Article CAS Google Scholar
  47. Perkins, N.D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523–527 (1997).
    Article CAS Google Scholar
  48. Harper, J.W., Hannon, G.J., Zhang, H., Casso, D. & Elledge, S.J. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).
    Article CAS Google Scholar
  49. Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993).
    Article CAS Google Scholar
  50. Deng, C., Zhang, P., Harer, W.J., Elledge, S.J. & Leder, P. Mice lacking p21WAF1/CIP1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
    Article CAS Google Scholar
  51. Hunter, T. & Pines, J. Cyclins and cancer: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).
    Article CAS Google Scholar
  52. Lemarie, E., Musset, M., Charbonnier, C., Renoux, M. & Renoux, G. Clinical characterization of Imuthipl. Methods Exp. Clin. Pharmacol. 8, 51–54 (1986).
    CAS Google Scholar
  53. Reisinger, E. et al. Inhibition of AIDS progression by dithiocarb. Lancet 335, 679–682 (1990).
    Article CAS Google Scholar
  54. Danielson, P.E. et al. p1b15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7, 261–267 (1988).
    Article CAS Google Scholar
  55. Kapiloff, M.S., Farkash, Y., Wegner, M. & Rosenfeld, M.G. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253, 786–789 (1991).
    Article CAS Google Scholar

Download references